CN1022914C - 新的1，3-二取代哌啶衍生物的制备方法 - Google Patents
新的1，3-二取代哌啶衍生物的制备方法 Download PDFInfo
- Publication number
- CN1022914C CN1022914C CN89104933A CN89104933A CN1022914C CN 1022914 C CN1022914 C CN 1022914C CN 89104933 A CN89104933 A CN 89104933A CN 89104933 A CN89104933 A CN 89104933A CN 1022914 C CN1022914 C CN 1022914C
- Authority
- CN
- China
- Prior art keywords
- formula
- alkyl
- group
- compound
- evaporated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC1=C(C(c2ccccc2)O*C(CCC2)CI2(C)#C)C=CCC1 Chemical compound CC1=C(C(c2ccccc2)O*C(CCC2)CI2(C)#C)C=CCC1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888816365A GB8816365D0 (en) | 1988-07-08 | 1988-07-08 | Therapeutic agents |
| GB8816365.4 | 1988-07-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1039415A CN1039415A (zh) | 1990-02-07 |
| CN1022914C true CN1022914C (zh) | 1993-12-01 |
Family
ID=10640168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN89104933A Expired - Fee Related CN1022914C (zh) | 1988-07-08 | 1989-07-08 | 新的1，3-二取代哌啶衍生物的制备方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5089505A (https=) |
| EP (1) | EP0350309B1 (https=) |
| JP (2) | JPH0739388B2 (https=) |
| KR (1) | KR930002728B1 (https=) |
| CN (1) | CN1022914C (https=) |
| AT (1) | ATE82262T1 (https=) |
| AU (1) | AU602453B2 (https=) |
| CA (1) | CA1336833C (https=) |
| DD (1) | DD284011A5 (https=) |
| DE (1) | DE68903437T2 (https=) |
| DK (1) | DK337589A (https=) |
| EG (1) | EG18853A (https=) |
| ES (1) | ES2052917T3 (https=) |
| FI (1) | FI94241C (https=) |
| GB (1) | GB8816365D0 (https=) |
| GR (1) | GR3006595T3 (https=) |
| HU (1) | HUT50771A (https=) |
| IE (1) | IE63438B1 (https=) |
| IL (1) | IL90792A0 (https=) |
| MX (1) | MX16728A (https=) |
| MY (1) | MY106976A (https=) |
| NO (1) | NO892828L (https=) |
| NZ (1) | NZ229865A (https=) |
| PL (2) | PL161887B1 (https=) |
| PT (1) | PT91081B (https=) |
| RU (2) | RU1838307C (https=) |
| YU (1) | YU135389A (https=) |
| ZA (1) | ZA895175B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231104A (en) * | 1988-07-08 | 1993-07-27 | Pfizer Inc. | 1-arylethyl-3-substituted piperidines |
| GB9000301D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Piperidine & pyrrolidine derivatives |
| GB9208230D0 (en) * | 1992-04-14 | 1992-05-27 | Pfizer Ltd | Treatment of delayed gastric emptying |
| US5340826A (en) * | 1993-02-04 | 1994-08-23 | Pfizer Inc. | Pharmaceutical agents for treatment of urinary incontinence |
| GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
| US6525069B1 (en) | 1998-12-18 | 2003-02-25 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| JP2002532427A (ja) * | 1998-12-18 | 2002-10-02 | デュポン ファーマシューティカルズ カンパニー | ケモカイン受容体活性のモジュレーターとしてのｎ−ウレイドアルキルピペリジン |
| EP1140087A4 (en) * | 1998-12-18 | 2002-04-03 | Du Pont Pharm Co | N-UREIDOALKYL-PIPERIDINES FOR USE AS MODULATORS OF THE ACTIVITY OF CHIMIOKIN RECEPTORS |
| US6331541B1 (en) | 1998-12-18 | 2001-12-18 | Soo S. Ko | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| AU2482100A (en) * | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| US6897234B2 (en) | 1999-12-17 | 2005-05-24 | Bristol-Myers Squibb Pharma Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| AR034257A1 (es) | 2000-06-30 | 2004-02-18 | Du Pont Pharm Co | Compuesto ureido, composicion farmaceutica que lo comprende y metodo para modular la actividad del receptor de quimiocinas |
| CA2422055A1 (en) * | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| US6508872B2 (en) * | 2001-02-26 | 2003-01-21 | Hewlett-Packard Company | Lightfast additive molecule for inkjet ink |
| WO2008144602A1 (en) * | 2007-05-18 | 2008-11-27 | Auspex Pharmaceuticals, Inc. | Deuterated zamifenacin derivatives |
| EP2578569B1 (en) * | 2010-05-27 | 2015-10-28 | ASKA Pharmaceutical Co., Ltd. | Heterocyclic ring compound and h1 receptor antagonist |
| CN107129453B (zh) * | 2016-02-26 | 2019-10-11 | 中国科学院大连化学物理研究所 | 化合物、毒蕈碱m受体拮抗剂、组合物及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA541598A (en) * | 1957-05-28 | Levy Joseph | N-substituted-4-benzhydryl etherpiperidines and method for obtaining the same | |
| GB688345A (en) * | 1951-02-19 | 1953-03-04 | Greenwood And Hughes Ltd | Improvements in sanitary liquid traps |
| US2745837A (en) * | 1954-01-21 | 1956-05-15 | Schering Corp | Benzhydryl ethers of alkyl piperidinols |
| GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
| US2974146A (en) * | 1956-02-24 | 1961-03-07 | Lakeside Lab Inc | 3-piperidyl benzhydryl ethers |
| NL237664A (https=) * | 1959-04-01 |
-
1988
- 1988-07-08 GB GB888816365A patent/GB8816365D0/en active Pending
-
1989
- 1989-06-29 IL IL90792A patent/IL90792A0/xx not_active IP Right Cessation
- 1989-07-05 MY MYPI89000908A patent/MY106976A/en unknown
- 1989-07-06 CA CA000604882A patent/CA1336833C/en not_active Expired - Fee Related
- 1989-07-06 AT AT89306881T patent/ATE82262T1/de not_active IP Right Cessation
- 1989-07-06 ES ES89306881T patent/ES2052917T3/es not_active Expired - Lifetime
- 1989-07-06 EP EP89306881A patent/EP0350309B1/en not_active Expired - Lifetime
- 1989-07-06 US US07/376,263 patent/US5089505A/en not_active Expired - Fee Related
- 1989-07-06 PT PT91081A patent/PT91081B/pt not_active IP Right Cessation
- 1989-07-06 EG EG32789A patent/EG18853A/xx active
- 1989-07-06 YU YU01353/89A patent/YU135389A/xx unknown
- 1989-07-06 DD DD89330509A patent/DD284011A5/de not_active IP Right Cessation
- 1989-07-06 DE DE8989306881T patent/DE68903437T2/de not_active Expired - Fee Related
- 1989-07-07 RU SU894614534A patent/RU1838307C/ru active
- 1989-07-07 PL PL89280474A patent/PL161887B1/pl unknown
- 1989-07-07 PL PL89283209A patent/PL162318B1/pl unknown
- 1989-07-07 NO NO89892828A patent/NO892828L/no unknown
- 1989-07-07 FI FI893326A patent/FI94241C/fi not_active IP Right Cessation
- 1989-07-07 DK DK337589A patent/DK337589A/da not_active Application Discontinuation
- 1989-07-07 KR KR1019890009671A patent/KR930002728B1/ko not_active Expired - Fee Related
- 1989-07-07 NZ NZ229865A patent/NZ229865A/en unknown
- 1989-07-07 HU HU893449A patent/HUT50771A/hu unknown
- 1989-07-07 IE IE220289A patent/IE63438B1/en not_active IP Right Cessation
- 1989-07-07 AU AU37971/89A patent/AU602453B2/en not_active Ceased
- 1989-07-07 ZA ZA895175A patent/ZA895175B/xx unknown
- 1989-07-07 MX MX1672889A patent/MX16728A/es unknown
- 1989-07-08 CN CN89104933A patent/CN1022914C/zh not_active Expired - Fee Related
- 1989-07-10 JP JP1177854A patent/JPH0739388B2/ja not_active Expired - Fee Related
-
1990
- 1990-09-17 RU SU904831151A patent/RU1836364C/ru active
-
1992
- 1992-12-21 GR GR920403003T patent/GR3006595T3/el unknown
-
1994
- 1994-07-26 JP JP6173882A patent/JPH07157469A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1022914C (zh) | 新的1，3-二取代哌啶衍生物的制备方法 | |
| CN1024547C (zh) | 一类环胺化合物的制备方法 | |
| CN1056605C (zh) | 作为人速激肽ⅲ受体的选择性拮抗剂的化合物及其用途 | |
| CN1231468C (zh) | 化合物 | |
| CN1261430C (zh) | 作为阿立新受体拮抗剂应用的苯并氮杂卓及其杂环衍生物 | |
| CN1146540C (zh) | 具有镇痛作用的新化合物及其用途 | |
| CN1028105C (zh) | 四氢吡啶衍生物的制备方法 | |
| CN1046268C (zh) | 二氢吲哚-2-酮衍生物 | |
| CN1187342C (zh) | 取代的1－氨基烷基内酰胺化合物及其作为毒蕈碱受体拮抗剂的用途 | |
| CN1035178C (zh) | 芳酰胺衍生物 | |
| CN1191246C (zh) | 作为抗组胺剂和抗过敏剂的吲哚基哌啶衍生物 | |
| CN1653062A (zh) | 作为nmda受体阻断剂的(咪唑－1－基－甲基)－哒嗪 | |
| CN1478092A (zh) | 苯并噁嗪酮衍生物及其制备和应用 | |
| CN1599722A (zh) | 作为毒蕈碱受体拮抗剂的4－哌啶基烷基胺衍生物 | |
| CN1054600A (zh) | 新的胆碱酯酶抑制剂三环—环胺 | |
| CN1183907C (zh) | 新的咪唑啉化合物、其制备方法和含有它们的药物组合物 | |
| CN1044652A (zh) | 吡咯烷化合物和其药物用途 | |
| CN1041583A (zh) | 蝇蕈碱受体拮抗剂 | |
| CN1099752A (zh) | 新型酰氨烷基-和亚氨烷基-哌嗪 | |
| CN1160332C (zh) | 用于治疗抑郁症的n-芳氧基乙基胺衍生物 | |
| CN1823036A (zh) | 新的二苯并[b,f]氧杂䓬－10－甲酰胺及其药物用途 | |
| CN1345317A (zh) | (1－苯甲酰甲基－3－苯基－3－哌啶基乙基)哌啶衍生物,制备它们的方法以及包含它们的药物组合物 | |
| CN100338037C (zh) | 新的苯甲酰基哌啶化合物 | |
| CN1336821A (zh) | 取代的1－(哌啶－4－基)－3－芳基异硫脲、其制备方法及其在治疗中的应用 | |
| CN101048161A (zh) | 芳硫基苄基哌啶衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |